Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis.
Mulder C, Rupert S, Setiawan E, Mambetova E, Edo P, Sugiharto J, Useni S, Malhotra S, Cook-Scalise S, Pambudi I, Kadyrov A, Lawanson A, van den Hof S, Gebhard A, Juneja S, Sohn H.
Mulder C, et al. Among authors: malhotra s.
BMJ Glob Health. 2022 Jan;7(1):e007182. doi: 10.1136/bmjgh-2021-007182.
BMJ Glob Health. 2022.
PMID: 34992077
Free PMC article.